MEDDX | MEDGX | MEDDX / MEDGX | |
Total Expense Ratio | 1.81 | 0.81 | 223% |
Annual Report Gross Expense Ratio | 1.82 | 0.82 | 222% |
Fund Existence | 16 years | 16 years | - |
Gain YTD | -1.298 | -1.063 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.81B | 6.81B | 100% |
Annual Yield % from dividends | 5.76 | 6.76 | 85% |
Returns for 1 year | 3.97 | 5.01 | 79% |
Returns for 3 years | 7.95 | 11.22 | 71% |
Returns for 5 years | 11.87 | 17.51 | 68% |
Returns for 10 years | 18.46 | 30.96 | 60% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DISCX | 20.73 | N/A | N/A |
BNY Mellon International Stock Fund C | |||
UBPSX | 10.74 | N/A | N/A |
ProFunds UltraLatin America Svc | |||
IEMFX | 29.79 | N/A | N/A |
T. Rowe Price Instl Emerging Mkts Eq | |||
MSIBX | 16.67 | N/A | N/A |
Morgan Stanley Inst Passport ovrs eq A | |||
EIVCX | 12.09 | N/A | N/A |
Allspring Special Large Cap Value C |